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average length of about 27 and 55 nucle-
otides. The association of these RNAs with 
recPrP reconstituted an infectious TSE agent 
showing in hamster brain strain characteris-
tics slightly different from 263 K infectious 
agent (Simoneau et al., 2009).
As currently recognized, the demonstra-
tion of the prion hypothesis should be per-
formed in wild-type (wt) animals. However 
I suggest that comprehensive proof of the 
causal agent of TSEs is composed exclu-
sively of an infectious PrPsc protein can only 
be obtained when experimentation meets 
four requirements. This tetrad of rules is 
equivalent to Koch’s postulates for micro-
bial agents, namely that:
1.  In vitro conversion of pure (e.g., recom-
binant) PrPc to PrPsc is required.
2.  Experiments  should  be  performed 
using wt animals.
3.  Infected animals should develop fatal 
TSEs.
4.  Transmissibility  of  the  disease 
at  the  second  passage  should  be 
demonstrated.
In the first study (Makarava et al., 2010) 
the authors inoculated different preparations 
of recPrP in hamsters. Though they use wt 
animals in accord with the second require-
ment, they fail to meet the first criterion. 
Indeed the key inoculum produced from 
a pure solution of recPrP fibrils remains 
innocuous, i.e., fails to cause disease. This 
recPrP is effective only if it is “activated” by 
an “annealing”  process  involving  normal 
hamster brain homogenate (NHB). Other 
components may well have been incorpo-
rated from NHB. Moreover, the preparation 
induces a TSE-like disease only on second 
passage: the original inoculum did not have 
the ability to cause the TSE disease charac-
terized at second pass; therefore the third 
condition is not met. Though a new scrapie 
agent has been created, the experimental 
context does not allow to know for sure that 
it is derived from converted recPrP alone. 
Is RNA critical for the production of TSE infection?
Jean-Guy Fournier*
CEA/DSV/IMETI/SEPIA, Fontenay aux Roses, France
*Correspondence: jean-guy.fournier@cea.fr
A commentary on
Recombinant prion protein induces a new 
transmissible prion disease in wild-type 
animals.
by Makarava, N., Kovacs, G. G., Bocharova, 
O., Savtchenko, R., Alexeeva, I., Budka, H., 
Rohwer, R. G., and Baskakov, I. V. (2010). 
Acta Neuropathol. 119, 177–187.
Generating  a  prion  with  bacterially 
expressed recombinant prion protein.
by Wang, F., Wang, X., Yuan, C. G., and Ma, 
J. (2010). Science 327, 1132–1135.
Mammalian prions generated from bacteri-
ally expressed prion protein in the absence 
of any mammalian cofactors.
by Kim, J., Kim, J. I., Cali, I., Surewicz, K., 
Kong, Q., Raymond, G. J., Atarashi, R., Race, 
B., Qing, L., Gambetti, P., Caughey, B., and 
Surewicz, W. K. (2010). J. Biol. Chem. 285, 
14083–14087.
The prion hypothesis proposed by Prusiner 
(1998) stipulates that the causal agent of 
transmissible  spongiform  encephalopa-
thies (TSEs) is composed exclusively of an 
infectious  protein  (PrPsc)  produced  after 
structural conversion of a cellular protein 
(PrPc). Recently, three studies attempting to 
test predictions arising from this hypoth-
esis  have  been  published  by  Makarava 
et al. (2010),Wang et al. (2010), and Kim 
et al. (2010).
Paying particular attention to the molec-
ular composition of inocula inducing TSE 
disease reported in these investigations, I 
plan to discuss here, how these novel find-
ings  complement  our  previous  results 
(Simoneau et al., 2009). In a pioneer work, 
we substantiated the idea that the require-
ment of a cofactor may be indispensable for 
the acquisition of converted recombinant 
prion  protein  (recPrP)  infectivity.  Our 
results indicate that this crucial cofactor 
extracted from 263 K PrPsc is composed of 
two populations of small RNA having an 
Indeed, the inocula have had to undergo a 
long maturation step during the first pas-
sage (661 days). One could presume that 
converted recPrP, associated in a first step 
with endogenous RNA (present in NHB), is 
capable of inducing in the first brain the pro-
gressive synthesis of PrPsc and small RNA. 
The association (PrPsc–small RNA) we have 
reported (Simoneau et al., 2009) would form 
the infectious agent which inoculated in the 
second brain would induce overt TSE.
In a similar way to Makarava’s work, the 
approach by Wang et al. (2010) of using 
wt  animals  to  test  the  prion  hypothesis 
is compromised by the incorporation of 
RNA into the inoculum. Infection is only 
achieved by adding some critical compo-
nents to the recPrP solution, such as RNA 
(extracted from mouse liver) and synthetic 
phospholipid molecules, followed by a very 
extensive protein misfolding cyclic amplifi-
cation (PMCA). The putative importance 
of  the  host  RNA  in  this  sophisticated 
preparation has not been explored or even 
debated. We must ask whether it is catalytic 
or not, imposing control on whether recPrP 
is associated or not with RNA. We can also 
ask what its molecular characteristics are: 
single or double stranded, short or long 
lengths  and,  eventually,  what  sequence? 
The role of RNA could be evaluated sim-
ply  using  inoculum  containing  recPrP 
without RNA.
The third study (Kim et al., 2010) used 
the classical PMCA reaction combined with 
PrPsc  to  convert  recombinant  PrP. Again 
the solution destined to be injected is not 
as the authors believe, of absolute recPrP 
purity. They used PrPsc partially purified 
from  263  K-infected  hamster  brain.  In 
these conditions, native PrPsc is known to be 
highly contamined by nucleic acids particu-
larly RNA a key factor for the acquisition 
of PMCA product infectivity (Geoghegan 
et al., 2007). On this basis, the crucial con-
trol would have been to assess the response 
of  RNAse  treatment  on  the  preparative 
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So  the  fundamental  question  as  sug-
gested by Supattapone (2010), is what phe-
nomenon  metamorphoses  an  innocuous 
recPrP preparation into an infectious one? 
It seems that a conversion step alone is not 
sufficient to obtain this objective. Rather, 
co-factors, RNA in some cases, appear to 
be necessary.
In conclusion, if one considers that the 
tetrad of rules that should be respected for 
a  definitive  demonstration  of  the  prion 
hypothesis, ambiguities remain that should 
be clarified, with respect to the involvement 
of RNA.
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